European Neurotech Investing and Partnering Summit 2013

Helsinki, Finland
Wednesday, September 04, 2013



2nd European Neurotech Investing & Partnering Summit 2013
Drugs, Devices and Diagnostics for the Brain and Nervous System

September 4-5, 2013
Scandic Grand Marina and Congress Center

The summit features keynotes on the state of the European neurotech industry, cutting edge company presentations, leading investor analysis, outstanding translational research projects, and panel discussions on a comprehensive selection of topics. 

Hear about next generation treatments emerging in the EU for Alzheimer's, addiction, anxiety, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.

One-on-One Meetings

Registered Attendees can log into an attendee directory to set up meetings with opt-in participants.

Advisory Board

Neurotech EU was planned with the assistance of top European neurotech investors and thought leaders:

Johan Christenson, Partner, HealthCap

Francesco De Rubertis, Partner, Index Ventures
Kent Hansen, CEO, Danish Venture Management
Casey Lynch, Managing Director, NeuroInsights

Manuel Lopez-Figueroa, Vice President, Bay City Capital

Peter Moldt, Partner, Novo Ventures

Antoine Papiernik, Managing Partner, Sofinnova Ventures & MD Start

John Reppas, Director, Neurotechnology Industry Organization

Killu Sanborn, Director of Business Development, Oxford Finance
Indrek Tammeaid, Managing Director, Finsight 

Conference Highlights

At The Neurotech EU Summit you'll get a first-hand glimpse of What's in the Pipeline

  • Find out about new product licensing and partnering opportunities
  • Meet the European investors and find out what they are looking for 
  • Discover European partners key to your development and commercialization strategy
  • Discuss international market, capital and collaboration dynamics
  • Discover emerging technologies and companies
  • Learn about cutting edge translational research and funding opportunities
  • Plan networking and schedule meetings ahead of time with other attendees

Cancellation Policy

After August 1st, due to commitments to vendors, no refunds are available for cancellations or no-shows. Prior to August 1st, cancellations will be charged a $300 processing fee.  Registrations are transferable to new attendee prior to the conference.


To request a media pass please send relevant information to

Contact Us

Contact us to find out about Sponsorship opportunities. Sponsorship identifies your company as a leading organization in the neurotech community. NeuroInsights will work with you to create a customized package that meets your marketing needs.


Contact Information





Copyright © 2014 The Active Network, Inc.